Clinical Trial Update: Once a Day Use of Lactobacillus Casei Shirota on HIV-infected Patients Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated daily Lactobacillus casei Shirota in HIV infection; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lactobacillus Casei Shirota (Lactobacillus casei Shirota)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: HIV | Phase 2 | Status: COMPLETED